Pharmacogenetics of Membrane Transporters: An Update on Current Approaches

被引:96
|
作者
Sissung, Tristan M. [2 ]
Baum, Caitlin E. [1 ]
Kirkland, C. Tyler [1 ]
Gao, Rui [1 ]
Gardner, Erin R. [3 ]
Figg, William D. [1 ,2 ]
机构
[1] NCI, Mol Pharmacol Sect, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Clin Pharmacol Program, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[3] NCI, Clin Pharmacol Program, SAIC Frederick, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
ABCB1; ABCC1; ABCC2; ABCG2; OATP1B3; OATP1B1; Pharmacogenetics; Membrane transporters; SINGLE NUCLEOTIDE POLYMORPHISMS; CANCER RESISTANCE PROTEIN; HUMAN MDR1 GENE; OATP1B1; OATP-C; P-GLYCOPROTEIN; ORGANIC ANION; IN-VITRO; ORAL BIOAVAILABILITY; FUNCTIONAL-CHARACTERIZATION; MULTIDRUG TRANSPORTERS;
D O I
10.1007/s12033-009-9220-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.
引用
收藏
页码:152 / 167
页数:16
相关论文
共 50 条
  • [31] IMAGING OF BLADDER CANCER: UPDATE ON CURRENT APPROACHES FOR DIAGNOSIS
    Turkbey, B.
    Turkbey, E. Bengi
    Ravizzini, G.
    Karcaaltincaba, M.
    JBR-BTR, 2011, 94 (04): : 178 - 184
  • [32] Current approaches in SELEX: An update to aptamer selection technology
    Darmostuk, Mariia
    Rimpelova, Silvie
    Gbelcova, Helena
    Ruml, Tomas
    BIOTECHNOLOGY ADVANCES, 2015, 33 (06) : 1141 - 1161
  • [33] Current progress in pharmacogenetics
    Blakey, John D.
    Hall, Ian P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 824 - 831
  • [34] CURRENT PROBLEMS OF PHARMACOGENETICS
    KUDRIN, AN
    BABKINA, TA
    PASHIN, YV
    TERAPEVTICHESKII ARKHIV, 1976, 48 (05) : 134 - 140
  • [35] Systems approaches for pharmacogenetics and pharmacogenomics
    Bader, Joel S.
    PHARMACOGENOMICS, 2008, 9 (03) : 257 - 262
  • [36] Data Science Approaches to Pharmacogenetics
    Penrod, N. M.
    Moore, J. H.
    CURRENT MOLECULAR MEDICINE, 2014, 14 (07) : 805 - 813
  • [37] Pharmacogenetics in Psychiatry: An Update on Clinical Usability
    van Schaik, Ron H. N.
    Muller, Daniel J.
    Serretti, Alessandro
    Ingelman-Sundberg, Magnus
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [38] Update on pharmacogenetics in epilepsy: a brief review
    Szoeke, CEI
    Newton, M
    Wood, JM
    Goldstein, D
    Berkovic, SF
    OBrien, TJ
    Sheffield, LJ
    LANCET NEUROLOGY, 2006, 5 (02): : 189 - 196
  • [39] Pharmacogenetics of therapies in rheumatoid arthritis: An update
    Babiker-Mohamed, Mohamed H.
    Bhandari, Sambhawana
    Ranganathan, Prabha
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2024, 38 (04):
  • [40] Pharmacogenetics of antidepressant response: an update.
    Drago A.
    De Ronchi D.
    Serretti A.
    Human Genomics, 3 (3) : 257 - 274